GNE-616
GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype selective Nav1.7 inhibitor (Ki of 0.79 nM and Kd of 0.38 nM for hNav1.7) for the treatment of chronic pain. GNE-616 shows >1000 nM Kd and >2500-fold selectivity over hNav1.1, hNav1.3, hNav1.4, and hNav1.5. Selectivity over hNav1.2 and hNav1.6 is more modest at 31- and 73-fold, respectively[1].
Product Specifications
CAS Number
2349371-81-7
UNSPSC
12352005
Target
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/gne-616.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=C(F)C=C2[C@@H](N3[C@@H](C4=NC=CC=C4)C[C@@H](C(F)(F)F)CC3)CCOC2=C1)(NC5=NC=NC=C5)=O
Molecular Formula
C24H23F4N5O3S
Molecular Weight
537.53
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Nav1.7
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![RFXANK Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3E7]](https://cdn.genprice.uk/products/937/68dd1b6d061270361ea1716f/imageurl/ta504271bm.webp)
RFXANK Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3E7]
1-(2-Chloroethoxy)-2-diethoxyphosphoryl-ethane
